학술논문
Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β-blocker atenolol.
Document Type
Article
Author
Source
Integrated Environmental Assessment & Management; Jul2010 Supplement 1, Vol. 6, p514-523, 10p
Subject
Language
ISSN
15513777
Abstract
Copyright of Integrated Environmental Assessment & Management is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)